Virotherapy, 2012 - Google Patents
Oncolytic virotherapy for ovarian cancerVirotherapy, 2012
View PDF- Document ID
- 5672558665909904883
- Author
- Virotherapy O
- Publication year
External Links
Snippet
In the past two decades, more than 20 viruses with selective tropism for tumor cells have been developed as oncolytic viruses (OVs) for treatments of a variety of malignancies. Of these viruses, eleven have been tested in human ovarian cancer models in preclinical …
- 206010061535 Ovarian neoplasm 0 title abstract description 184
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Szekely et al. | Immunological differences between primary and metastatic breast cancer | |
| Frank et al. | Clinical implications of colorectal cancer stem cells in the age of single-cell omics and targeted therapies | |
| Pruneri et al. | Tumor infiltrating lymphocytes in early breast cancer | |
| Cui et al. | Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression‐free survival for patients with hepatocellular carcinoma | |
| Bryan | Cell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomena | |
| Ho et al. | Analysis of the expression of repetitive DNA elements in osteosarcoma | |
| Chan et al. | E pstein–B arr virus‐associated lymphoepithelioma‐like cholangiocarcinoma: a rare variant of intrahepatic cholangiocarcinoma with favourable outcome | |
| Bezan et al. | MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapy | |
| Sasse et al. | Comparing long-term toxicity and efficacy of combined modality treatment including extended-or involved-field radiotherapy in early-stage Hodgkin's lymphoma | |
| JP2016174600A5 (en) | ||
| Santa-Maria et al. | Immune checkpoint inhibitor therapy in breast cancer | |
| Zhao et al. | Breast cancer immunology and immunotherapy: targeting the programmed cell death protein-1/programmed cell death protein ligand-1 | |
| Lin et al. | Next generation patient-derived prostate cancer xenograft models | |
| Kurebayashi et al. | Immune microenvironment of hepatocellular carcinoma, intrahepatic cholangiocarcinoma and liver metastasis of colorectal adenocarcinoma: Relationship with histopathological and molecular classifications | |
| MX2017015210A (en) | Compositions and methods for screening solid tumors. | |
| McFadden et al. | Genetics, diagnosis, and management of Hürthle cell thyroid neoplasms | |
| McLean et al. | Concurrent primary and metastatic cutaneous head and neck squamous cell carcinoma: analysis of prognostic factors | |
| Curé et al. | Prognostic value of residual node involvement in operable breast cancer after induction chemotherapy | |
| Saglam et al. | AKT, EGFR, C-ErbB-2, and C-kit expression in uterine carcinosarcoma | |
| Jana et al. | Prognostic significance of HER-2/neu and survival of breast cancer patients attending a specialized breast clinic in Kolkata, Eastern India | |
| Tsang et al. | Experimental models for ovarian cancer research | |
| de Deus et al. | Influence of IL10 (G1082A) and TNFα (G308A) Polymorphisms on the Survival of Pediatric Patients with ALL | |
| Virotherapy | Oncolytic virotherapy for ovarian cancer | |
| Turhal et al. | Prevalence of K-Ras mutations in hepatocellular carcinoma: AA Turkish Oncology Group pilot study | |
| Zhong et al. | Association of vascular endothelial growth factor polymorphisms with clinical outcome of renal cell carcinoma patients |